CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
暂无分享,去创建一个
J. Egen | J. Allison | C A Chambers | M S Kuhns | J G Egen | J P Allison | C. Chambers | M. Kuhns
[1] J. Bluestone,et al. CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301] , 1996, The Journal of experimental medicine.
[2] T. Mak,et al. Duration of TCR stimulation determines costimulatory requirement of T cells. , 1996, Immunity.
[3] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[4] T. Mak,et al. Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4 , 1996, Science.
[5] T. Strom,et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.
[6] R. Karr,et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.
[7] J. Bluestone,et al. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.
[8] T. Mak,et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. , 1998, Journal of immunology.
[9] T. Sullivan,et al. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. , 1996, International immunology.
[10] K. McCoy,et al. Protective Immunity to Nematode Infection Is Induced by CTLA-4 Blockade , 1997, The Journal of experimental medicine.
[11] D. Farber,et al. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation. , 1998, Journal of immunology.
[12] E. Jaffee,et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.
[13] K. Bennett,et al. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.
[14] S. Almo,et al. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. , 2000, Science.
[15] C. Thompson,et al. Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction1 , 2000, The Journal of Immunology.
[16] A. Lanzavecchia,et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. , 1999, Science.
[17] J. Allison,et al. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.
[18] J. Allison,et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.
[19] J. Allison,et al. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. , 1990, Journal of immunology.
[20] J. Allison,et al. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells , 1996, The Journal of experimental medicine.
[21] K. McCoy,et al. Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Can Regulate Dendritic Cell–induced Activation and Cytotoxicity of CD8+ T Cells Independently of CD4+T Cell Help , 1999, The Journal of experimental medicine.
[22] A. Weiss,et al. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites , 1997, Molecular and cellular biology.
[23] P. Linsley,et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.
[24] J. Allison,et al. The role of tyrosine phosphorylation and PTP‐1C in CTLA‐4 signal transduction , 1996, European journal of immunology.
[25] J. Allison,et al. CTLA-4-Mediated inhibition of early events of T cell proliferation. , 1999, Journal of immunology.
[26] D. Wraith,et al. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. , 1999, International immunology.
[27] J. Bluestone,et al. T cell co-stimulation and in vivo tolerance. , 1993, Current opinion in immunology.
[28] D. Harlan,et al. CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection , 1998, European journal of immunology.
[29] J. Allison,et al. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. , 2002, Blood.
[30] J. Lamb,et al. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. , 1999, Journal of immunology.
[31] J. Madrenas,et al. The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation1 , 2000, The Journal of Immunology.
[32] C. Benoist,et al. Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.
[33] A. Weiss,et al. ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR zeta in murine thymocytes and lymph node T cells. , 1994, Immunity.
[34] D I Stuart,et al. Structure and dimerization of a soluble form of B7-1. , 2000, Immunity.
[35] J. Bluestone,et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. , 1999, Journal of immunology.
[36] H. Nariuchi,et al. Polarization of Naive CD4+ T Cells Toward the Th1 Subset by CTLA-4 Costimulation1 , 2000, The Journal of Immunology.
[37] P. Nickerson,et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. , 1997, Journal of immunology.
[38] J. Allison,et al. The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses , 1996, Immunological reviews.
[39] M. Jenkins,et al. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.
[40] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[41] A. Kruisbeek,et al. Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Interferes with Extracellular Signal-regulated Kinase (ERK) and Jun NH2-terminal Kinase (JNK) Activation, but Does Not Affect Phosphorylation of T Cell Receptor ζ and ZAP70 , 1997, The Journal of experimental medicine.
[42] P. Blair,et al. Cutting Edge: CTLA-4 Ligation Delivers a Unique Signal to Resting Human CD4 T Cells That Inhibits Interleukin-2 Secretion but Allows Bcl-XL Induction , 1998, The Journal of Immunology.
[43] D. Baltimore,et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. , 1999, Immunity.
[44] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[45] J. Bluestone,et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.
[46] Peter S. Linsley,et al. Cytotoxic T Lymphocyte-associated Molecule-4, a High Avidity Receptor for CD80 and CD86, Contains an Intracellular Localization Motif in Its Cytoplasmic Tail (*) , 1995, The Journal of Biological Chemistry.
[47] J. Allison,et al. Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation , 1999, The Journal of experimental medicine.
[48] C. Lowenstein,et al. The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.
[49] T. Sullivan,et al. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. , 1997, Immunity.
[50] J. Allison,et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Bluestone,et al. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. , 1999, Journal of immunology.
[52] P. Linsley,et al. Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions* , 1996, The Journal of Biological Chemistry.
[53] H. Schneider,et al. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. , 1998, Journal of immunology.
[54] C. Benoist,et al. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] F. Denizot,et al. A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.
[56] G. Freeman,et al. Characterization of CTLA-4 structure and expression on human T cells. , 1993, Journal of immunology.
[57] J. Bluestone,et al. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. , 1998, Journal of immunology.
[58] Nitin J. Karandikar,et al. CTLA-4: a negative regulator of autoimmune disease , 1996, The Journal of experimental medicine.
[59] K. Bennett,et al. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. , 1997, Biochemistry.
[60] C. Langlet,et al. Membrane rafts and signaling by the multichain immune recognition receptors. , 2000, Current opinion in immunology.
[61] A. Khoruts,et al. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. , 1999, Immunity.
[62] B. Foster,et al. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Hutchcroft,et al. Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. , 1996, Journal of immunology.
[64] Masahiko Hibi,et al. JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.
[65] R. Germain,et al. CD4+ T cell survival is not directly linked to self-MHC–induced TCR signaling , 2000, Nature Immunology.
[66] C. Benoist,et al. Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.
[67] M. Azuma,et al. Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4. , 1999, International immunology.
[68] M. V. Vander Heiden,et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. , 1997, Journal of immunology.
[69] K. Tanaka,et al. Janus kinase 2 is associated with a box 1‐like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule‐4 , 2000, Journal of cellular biochemistry.
[70] J. Bonifacino,et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. , 1997, Immunity.
[71] C. Thompson,et al. Structural Analysis of CTLA-4 Function In Vivo1 , 2000, The Journal of Immunology.
[72] S. Nagata,et al. The Fas death factor , 1995, Science.
[73] É. Vivier,et al. Immunoreceptor Tyrosine-based Inhibition Motifs , 2012, Current Topics in Microbiology and Immunology.
[74] R. Schwartz,et al. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.
[75] J. Allison,et al. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.
[76] H. Schneider,et al. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. , 2000, Biochemical and biophysical research communications.
[77] L. Berg,et al. Cutting Edge: Two Distinct Mechanisms Lead to Impaired T Cell Homeostasis in Janus Kinase 3- and CTLA-4-Deficient Mice1 , 2001, The Journal of Immunology.
[78] Yuan Zhang,et al. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[79] C. Thompson,et al. Expression and function of CTLA-4 in Th1 and Th2 cells. , 1998, Journal of immunology.
[80] R. Flavell,et al. Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .
[81] A. Weiss,et al. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28 , 1992, Molecular and cellular biology.
[82] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[83] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[84] M. Jenkins. The ups and downs of T cell costimulation. , 1994, Immunity.
[85] A. Sharpe,et al. B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) , 1999, The Journal of experimental medicine.
[86] Seong-Jin Kim,et al. Disruption of T Cell Homeostasis in Mice Expressing a T Cell–Specific Dominant Negative Transforming Growth Factor β II Receptor , 2000, The Journal of experimental medicine.
[87] M. Davis,et al. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.
[88] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[89] B. Foster,et al. Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. , 2000, Cancer research.
[90] E. Simpson,et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.
[91] T. Kirchhausen,et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. , 1999, Journal of immunology.
[92] T. Mak,et al. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor‐transgenic CTLA‐4‐deficient mice , 1997, European journal of immunology.
[93] C. Monks,et al. Selective modulation of protein kinase C-Θ during T-cell activation , 1997, Nature.
[94] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[95] J. Madrenas,et al. CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression1 , 2000, The Journal of Immunology.
[96] S. Constant,et al. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.
[97] J. Bluestone,et al. Molecular basis of T cell inactivation by CTLA-4. , 1998, Science.
[98] C. June,et al. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. , 1996, Journal of immunology.
[99] J. Allison,et al. Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.
[100] P. Linsley,et al. CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.
[101] C. Thompson,et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.
[102] P. Linsley,et al. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. , 1993, Science.
[103] C. June,et al. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. , 1986, Journal of immunology.
[104] J. Allison,et al. CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition. , 1999, Cold Spring Harbor symposia on quantitative biology.
[105] K P Lee,et al. Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.
[106] J. Allison,et al. Activation and differentiation requirements of primary T cells in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[107] R. Abe,et al. Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Engagement Delivers an Inhibitory Signal through the Membrane-Proximal Region in the Absence of the Tyrosine Motif in the Cytoplasmic Tail , 1999, The Journal of experimental medicine.
[108] T. Honjo,et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.
[109] J. Allison,et al. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[110] A. Sharpe,et al. The role of CTLA-4 in regulating Th2 differentiation. , 1999, Journal of immunology.
[111] S. Wahl,et al. Engagement of Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor β (TGF-β) Production by Murine CD4+ T Cells , 1998, The Journal of experimental medicine.
[112] Ethan M. Shevach,et al. CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.
[113] J. Allison,et al. The emerging role of CTLA-4 as an immune attenuator. , 1997, Immunity.
[114] J. Allison,et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[115] P. Linsley,et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.
[116] J. Allison,et al. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse. , 2000, Journal of autoimmunity.
[117] G. Legname,et al. Long-term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck. , 2000, Science.
[118] J. Bluestone,et al. Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice. , 1998, Cancer research.
[119] J. Allison,et al. Manipulation of costimulatory signals to enhance antitumor T-cell responses. , 1995, Current opinion in immunology.
[120] J. Gribben,et al. CTLA4 mediates antigen-specific apoptosis of human T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[121] T. Mak,et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. , 1999, Journal of immunology.
[122] J. Allison,et al. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. Wilson,et al. TGF-β Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar1 , 2000, The Journal of Immunology.
[124] S. Bromley,et al. The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.
[125] R. Offringa,et al. Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp1001 , 2000, The Journal of Immunology.
[126] J. Allison,et al. Secondary but not primary T cell responses are enhanced in CTLA‐4‐deficient CD8+ T cells , 1998, European journal of immunology.
[127] S. Singer,et al. The specific direct interaction of helper T cells and antigen- presenting B cells. II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the bound helper T cells , 1987, The Journal of experimental medicine.
[128] J. Allison,et al. Thymocyte development is normal in CTLA-4-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[129] H. Reiser,et al. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[130] J. Bluestone,et al. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages. , 1997, Cancer research.
[131] H. Ruley,et al. H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.
[132] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[133] M. V. Heiden,et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. , 2000, Immunity.
[134] M. Bevan,et al. Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.
[135] P. Bousso,et al. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.